The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning

Autor: Ana Rajicic, Astrid A M van der Veldt, Arlette E. Odink, Lindsay Angus, Stefan Sleijfer, Stefan Klein, Wiro J. Niessen, Martijn P. A. Starmans, Mathilde Jalving, Jacob J. Visser

Publikováno v: Journal of Personalized Medicine, 11(4)
Journal of Personalized Medicine
Volume 11
Issue 4
Journal of Personalized Medicine, Vol 11, Iss 257, p 257 (2021)
Journal of personalized medicine, 11(4):257. MDPI AG
Journal of Personalized Medicine, 11(4):257. Multidisciplinary Digital Publishing Institute (MDPI)

Patients with BRAF mutated (BRAF-mt) metastatic melanoma benefit significantly from treatment with BRAF inhibitors. Currently, the BRAF status is determined on archival tumor tissue or on fresh tumor tissue from an invasive biopsy. The aim of this st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471a9b82aef684165dbfffd5a0d3a235
http://resolver.tudelft.nl/uuid:7f0c1dae-9f6b-41bd-a7c2-ae6efc53e1ff